Literature DB >> 23393667

Fulminant type 1 diabetes mellitus: a new class of type 1 diabetes.

Saeko Shibasaki1, Akihisa Imagawa, Toshiaki Hanafusa.   

Abstract

Fulminant Type 1 diabetes is a novel subtype of Type 1 diabetes. In this disease, extremely rapid and almost complete beta-cell destruction occurs, resulting in nearly no residual insulin secretion even just after the onset. The number of patients presumably amounts to 5,000-7,000 in Japan. The involvement of both, genetic background and viral infection, has been suggested in the pathogenesis of this disease. Diagnostic criteria were established by a committee of the Japan Diabetes Society in 2004. Intensive insulin therapy is a standard therapy. We should pay special attention to early development of microvascular complications in fulminant Type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23393667     DOI: 10.1007/978-1-4614-5441-0_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

2.  DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.

Authors:  N Bansal; C S Hampe; L Rodriguez; E O'Brian Smith; J Kushner; A Balasubramanyam; M J Redondo
Journal:  Diabet Med       Date:  2016-02-12       Impact factor: 4.359

3.  Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody.

Authors:  Michiru Shiba; Hidefumi Inaba; Hiroyuki Ariyasu; Shintaro Kawai; Yuko Inagaki; Shohei Matsuno; Hiroshi Iwakura; Yuki Yamamoto; Masahiro Nishi; Takashi Akamizu
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

4.  A Case of Fulminant Type 1 Diabetes with Gastric and Urinary Retention.

Authors:  Chuan Xing; Wenqian Zhao; Yanjun Wang
Journal:  Diabetes Ther       Date:  2018-11-20       Impact factor: 2.945

Review 5.  Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes.

Authors:  Remi J Creusot; Manuela Battaglia; Maria-Grazia Roncarolo; C Garrison Fathman
Journal:  Stem Cells       Date:  2016-02-09       Impact factor: 6.277

6.  Fulminant type 1 diabetes mellitus: Two case reports.

Authors:  Wei You; Jianming Yang; Yanqun Liu; Wen Wang; Li Zhu; Wei Wang; Jun Yang; Fangyuan Chen
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.